Glycobiology Advance Access originally published online on December 3, 2007
Glycobiology 2008 18(2):158-165; doi:10.1093/glycob/cwm129
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Communication |
Sensitive detection of isoglobo and globo series tetraglycosylceramides in human thymus by ion trap mass spectrometry
2 Department of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77054, USA
3 Institute of Biomedicine, Department of Medical Biochemistry and Cell Biology, Göteborg University, SE-40530 Göteborg, Sweden
4 Howard Hughes Medical Institute, Department of Pathology and Committee of Immunology, University of Chicago, Chicago, IL 60637, USA
5 Department of Chemistry, University of New Hampshire, Durham, NH 03824-3598, USA
1 To whom correspondence should be addressed: Tel: +1-713-792-3134; Fax: +1-713-563-3424; e-mail: dzhou{at}mdanderson.org and Tel: +1-603-862-2529; Fax: +1-603-862-4278; e-mail: slevery{at}cisunix.unh.edu
Received on September 30, 2007; revised on November 25, 2007; accepted on November 28, 2007
Glycosphingolipids serve as ligands for receptors involved in signal transduction and immune recognition, as exemplified by isoglobotrihexosylceramide, an antigenic ligand for T cell receptors. Mechanistic studies on the regulation of isoglobotrihexosylceramide require biochemical measurement of its lysosomal precursor, isoglobotetraglycosylceramide. It remains a challenge to distinguish between complex tetraglycosylceramide glycosphingolipid isomers with the same sugar components but diverse internal linkages. Here we established a simple and sensitive method to separate globo- and isoglobotetraglycosylceramide by MS5 ion trap mass spectrometry, and report the identification of isoglobotetraglycosylceramide in a CHO cell line transfected by iGb3 synthase, as well as in human thymus.
Key words: CD1d / glycosphingolipid / ion trap MS / isoglobotetraglycosylceramide / natural killer T cells